Behavior of HO-1-N-1, buccal mucosa carcinoma derived cells, on [Ca2+]i responses to stimulants

J Oral Sci. 2002 Jun;44(2):103-8. doi: 10.2334/josnusd.44.103.

Abstract

Buccal mucosa carcinoma-derived cell line, HO-1-N-1, epithelial-like cells, was obtained in order to investigate the characteristics of oral cancer cells and examine the [Ca2+]i responses to stimulants, such as bradykinin (BK), histamine (HIST), thapsigargin (TG), epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha ). Intracellular Ca2+ influx was observed by all stimulants that enhanced the [Ca2+]i response. However, intracellular Ca2+ release was not observed in response to growth factors. The [Ca2+]i response of BK (100 nM) was inhibited by 10 micro M of the BKB2 antagonist, D-Arg-[Hyp3, Thi5,8, D-Phe7]-BK, and HIST (1 mM) was completely inhibited by 100 nM of the H1 antagonist, (+)-chlorpheniramine, in the presence and absence of extracellular Ca2+ (1.5 mM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bradykinin / antagonists & inhibitors
  • Bradykinin / pharmacology
  • Calcium / metabolism*
  • Calcium Signaling / drug effects*
  • Carcinoma / metabolism*
  • Carcinoma / pathology
  • Epidermal Growth Factor / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Histamine / pharmacology
  • Histamine H1 Antagonists / pharmacology
  • Humans
  • Mouth Mucosa / pathology
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology
  • Receptors, Cell Surface / metabolism
  • Stimulation, Chemical
  • Thapsigargin / pharmacology
  • Transforming Growth Factor alpha / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism*

Substances

  • Histamine H1 Antagonists
  • Receptors, Cell Surface
  • Transforming Growth Factor alpha
  • Epidermal Growth Factor
  • Thapsigargin
  • Histamine
  • Bradykinin
  • Calcium